Please sign in to follow a disease.
Ovarian
Clinical trials for Ovarian explained in plain language.
Never miss a new study
Get alerted when new Ovarian trials appear
Sign up with your email to follow new studies for Ovarian, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug takes aim at ovarian cancers that resist platinum chemotherapy
Disease control OngoingResearchers are testing an experimental drug called IBI354 in people with ovarian, primary peritoneal, or fallopian tube cancer that has stopped responding to platinum-based chemotherapy. The trial compares IBI354 given alone with one of four standard chemotherapy drugs chosen by…
Matched conditions: OVARIAN
Phase 3 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New drug cocktail shows promise for tough cancers
Disease control OngoingThis study is testing a combination of three drugs—durvalumab (an immunotherapy), olaparib (a targeted therapy), and bevacizumab (a drug that blocks blood vessel growth)—in people with advanced solid tumors, including ovarian, breast, lung, and gastric cancers. The goal is to see…
Matched conditions: OVARIAN
Phase 1/2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC